Trial register facet
Trial records for Maridebart cafraglutide
10 records for Maridebart cafraglutide, of which 3 are published trials.
Showing 0 records on this page
Records
10 documents
Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.
| Record | Compound | Phase | Status | Design | Randomised | Year | Certainty |
|---|---|---|---|---|---|---|---|
| MARITIDE-PH2-OBESITY | Maridebart cafraglutide | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | 592 | 2024 | Low |
| MARITIDE-PH2-T2D | Maridebart cafraglutide | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 2024 | Low |
| MARITIDE-PH2-OBESITY-HEPATIC-IMPprogramme record | Maridebart cafraglutide | Phase 1 | Reported | Phase 1 ascending dose | — | 2024 | Very low |
| MARITIDE-PH2-T2D-REGIONAL-JPprogramme record | Maridebart cafraglutide | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 2024 | Very low |
| MARITIDE-PH2-T2D-BODY-COMPprogramme record | Maridebart cafraglutide | Phase 2 | Reported | Randomised, double-blind, placebo-controlled | — | 2024 | Very low |
| MARITIDE-PH2-T2D-REGIONAL-CNprogramme record | Maridebart cafraglutide | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 2024 | Very low |
| MARITIDE-PH3 | Maridebart cafraglutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Not rated |
| MARITIDE-PH3-RENAL-IMPprogramme record | Maridebart cafraglutide | Phase 1 | Ongoing | Phase 1 ascending dose | — | — | Very low |
| MARITIDE-PH3-HEPATIC-IMPprogramme record | Maridebart cafraglutide | Phase 1 | Ongoing | Phase 1 ascending dose | — | — | Very low |
| MARITIDE-PH3-BIOMARKERprogramme record | Maridebart cafraglutide | Phase 3 | Ongoing | Randomised, double-blind, placebo-controlled | — | — | Very low |